Tilray Brands Insider Purchases: Penny Stock Insights Tilray Brands Insider Purchases: Penny Stock Insights

Avatar photo

The Dow Jones index closed higher by over 200 points on Thursday. Insider transactions can provide a window into a company’s prospects – a sign of confidence or concern. For traders keen on penny stocks, it’s a piece of the puzzle to factor into investment decisions.

Here’s a look at recent insider transactions for a few notable penny stocks. For more, explore Benzinga’s insider transactions platform.


Insider Action: Catheter Precision


  • The Trade: Catheter Precision, Inc. VTAK Director, Executive Chairman and CEO David A Jenkins acquired a total of 16,263 shares at an average price of $0.39. The cost of these shares amounted to around $6,323.
  • What’s Happening: Catheter Precision’s VIVO System was highlighted in a case study in EP Lab Digest.
  • Company Overview: Catheter Precision Inc., formerly Ra Medical Systems Inc., is a commercial-stage medical device company focused on cardiac electrophysiology, or EP.


Insider Action: ADM Endeavors


  • The Trade: ADM Endeavors, Inc. ADMQ CEO Marc Johnson acquired a total of 1,100 shares at an average price of $0.04. The cost of acquisition was around $45.10.
  • What’s Happening: The company’s stock surged approximately 38% over the past month.
  • Company Overview: ADM Endeavors Inc. operates a diverse, vertically integrated business encompassing retail sales, screen print promotions, embroidery production, digital production, import wholesale sourcing, and uniforms.


See Also: SLB, Travelers Companies And 3 Stocks To Watch Heading Into Friday


Insider Action: Tilray Brands


  • The Trade: Tilray Brands, Inc. TLRY Chief Strategy Officer Denise M Faltischek acquired a total of 10,000 shares at an average price of $2.05, amounting to an insider investment of around $20,500.
  • What’s Happening: An SEC filing revealed Tilray’s assignment and assumption agreement with Double Diamond Holdings Ltd. (DDH) on Jan. 9.
  • Company Overview: Tilray is a Canadian producer involved in the cultivation and sale of medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and rebranded itself as Tilray.


Don’t forget to check out our premarket coverage here







The free Daily Market Overview 250k traders and investors are reading

Read Now